A Phase I Study of Fludarabine, Cytarabine, and Oxaliplatin in Patients with Relapsed or Refractory Acute Myeloid Leukemia

PURPOSE: The combination of cytarabine and fludarabine was associated with superior clinical outcomes compared to high-dose cytarabine in relapse acute myeloid leukemia (AML). We conducted a phase I study combining oxaliplatin with cytarabine and fludarabine for patients with relapsed or refractory...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Lymphoma Myeloma Leuk
Main Authors: Tsimberidou, Apostolia-Maria, Keating, Michael J., Jabbour, Elias J, Ravandi-Kashani, Farhad, O'Brien, Susan, Estey, Elihu, Bekele, Neby, Plunkett, William K., Kantarjian, Hagop, Borthakur, Gautam
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4387892/
https://ncbi.nlm.nih.gov/pubmed/24637132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2014.01.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados